Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop

The Journal of Allergy and Clinical Immunology In Practice(2020)10.1016/j.jaip.2020.02.023Source: DataRank Database

Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 7.08)OA: bronzeTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (26)

Fuad M. Baroody ORCID,Claus Bachert ORCID,Benjamin S. Bleier ORCID,Larry Borish ORCID,Erica Brittain ORCID

Live enrichment

PubMed:32142964 PMC:PMC8177483 OpenAlex:https://openalex.org/W3009850785

NIAID NIH HHS

Grant: P01 AI145818

NIAID NIH HHS

Grant: R01 AI137174

NIDCD NIH HHS

Grant: T32 DC000022

NCATS NIH HHS

Grant: UL1 TR001863

Roche

Sanofi

Medtronic

National Institutes of Health

Aldeyra Therapeutics

Novartis

American Chemistry Council

AstraZeneca

Genentech

GlaxoSmithKline

Washington University School of Medicine in St. Louis

Astellas Pharma US

Otsuka America

Sanofi Genzyme

FWCI

7.08

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttp://www.jaci-inpractice.org/article/S2213219820301835/pdf

publisherhttp://www.jaci-inpractice.org/article/S2213219820301835/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213219820301835?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213219820301835?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaip.2020.02.023

Fields of Study

Sinusitis and nasal conditionsAllergic Rhinitis and SensitizationNasal Surgery and Airway StudiesBiological ProductsChronic DiseaseClinical Trials as TopicHumansNasal PolypsNational Institute of Allergy and Infectious Diseases (U.S.)Observational Studies as TopicRhinitisSinusitisUnited States

MeSH Terms

Biological ProductsChronic DiseaseClinical Trials as TopicHumansNasal PolypsRhinitisSinusitisUnited StatesNational Institute of Allergy and Infectious Diseases (U.S.)Observational Studies as Topic

Keywords

MedicineNasal polypsChronic rhinosinusitisAllergyDermatologyIntensive care medicineFamily medicineImmunologyClinical TrialsOutcomesRhinosinusitisOmalizumabMepolizumabNasal PolyposisType 2 InflammationDupilumab